Skip to main content

Suspension of electricity tarrif increase in public interest – NERC

Suspension of electricity tarrif increase in public interest – NERC

Suspension of electricity tarrif increase in public interest – NERC

The Nigerian Electricity Regulatory Commission (NERC) on Wednesday said that its order to suspend the recent tariff increase was done in the public interest.

Mr Dafe Akpeneye, Commissioner, Legal Licensing and Compliance, NERC, disclosed this at the virtual 2020 Businessday Energy Series – Fuel of the Future (Gas) Summit.

The summit had the theme: “Nigeria at 60: Harnessing Nigeria’s Energy Potential for the Future”.

The News Agency of Nigeria (NAN) reports that NERC issued an order to electricity Distribution Companies (DisCos) to suspend the implementation of the Service Reflective Tariff (SRT), effective Sept. 28 to Oct. 11.

Akpeneye said the suspension would enable further consultations and finalisation of negotiations between the Federal Government and labour unions who kicked against the tariff hike.

He said: “The gesture was done in good faith by the government and NERC as a regulator is bound by Section 33 of the Electric Power Sector Reform Act 2005, to comply with general policy directions concerning electricity from the minister.

” It says the commission shall take into consideration in discharging its functions under section 32(2), provided that such directions are not in conflict with this Act or the Constitution of the Federal Republic of Nigeria.

READ ALSO: Major reason FG suspended electricity tariff hike

“Looking at the overriding public interest on this issue, we saw that this is a valid policy directive and we issued the order to suspend the tariffs review from Sept. 28 to Oct. 11, to enable parties to continue with their negotiations.”

According to him, the Multi-Year Tariff Order (MYTO) 2020, was approved by NERC for the DisCos with effect from Sept. 1 after series of dialogue with all stakeholders in the industry.

He noted that the last MYTO was done in 2015 but became effective in 2016.

Akpeneye added that the new review was done to ensure that rates charged by DisCos were fair to customers.

He said it was also to ensure that DisCos operate efficiently to recover the full cost of their activities, including a reasonable return on the capital invested in the business.

The commissioner explained that the rationale behind the SRT was to ensure that the issue of blank increment in tariffs for all customers was removed.

“The SRT is an innovation to remove unfairness in billing customers. The customers have been placed in Bands A, B, C, D and E depending on their hours of electricity supply.

“Only customers enjoying daily supply of 12 hours of electricity and above (Bands A, B and C) are affected by the increment and the DisCos must guarantee these hours of supply to the locations, ” he said.

NAN

Vanguard News Nigeria

The post Suspension of electricity tarrif increase in public interest – NERC appeared first on Vanguard News.


by David O Royal via Vanguard News https://ift.tt/36pQY9l Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more